Autopsy diagnosis of 21-hydroxylase deficiency CAH in a case of apparent SIDS

Pediatric and Developmental Pathology

Volumn 8, Issue 3, 2005, Pages 397-401

  Gozzi, Tiziana G ^a   Harris, Naomi P ^a   McGown, Ivan N ^e   Cowley, David M ^e   Cotterill, Andrew M ^e   Campbell, Peter E ^c   Anderson, P Kym ^d   Warne, Garry L ^a,b  

^a ROYAL CHILDREN'S HOSPITAL   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

^c VICTORIAN INSTITUTE OF FORENSIC MEDICINE   (Australia)

^d GEELONG HOSPITAL   (Australia)

^e MATER CHILDREN S HOSPITAL   (Australia)

Author keywords

21 Hydroxylase deficiency; Congenital adrenal hyperplasia; Neonatal screening; Sudden infant death syndrome

Indexed keywords

ALLELE; ARTICLE; AUTOPSY; BLOOD TESTIS BARRIER; CASE REPORT; DISEASE SEVERITY; GENE MUTATION; GENETIC ANALYSIS; HETEROZYGOSITY; HOSPITAL DISCHARGE; HUMAN; INFANT; MALE; PRIORITY JOURNAL; SEXUAL DEVELOPMENT; SKIN FIBROBLAST; STEROID 21 MONOOXYGENASE DEFICIENCY; URINALYSIS;

ADRENAL GLANDS; ADRENAL HYPERPLASIA, CONGENITAL; AUTOPSY; HUMANS; INFANT; MALE; MUTATION; STEROID 21-HYDROXYLASE; SUDDEN INFANT DEATH;

EID: 23944468743     PISSN: 10935266     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10024-005-0004-0     Document Type: Article

References (14)

1. Gassner HL, Toppari J, Gonzalez SQ, Miller WL. Near-miss apparent SIDS from adrenal crisis. J Pediatr 2004;145:178-183.
2. White PC, Speiser PW. Congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Endocr Rev 2000;21:245-291.
3. Kovacs J, Votava F, Heinze G, Solyom J, Lebl J, Pribilincova Z, et al. Middle European Workshop on Paediatric Endocrinology-Congenital Adrenal Hyperplasia Study Group. Lessons from 30 years of clinical diagnosis and treatment of congenital adrenal hyperplasia in five middle European communities. J Clin Endocrinol Metab 2001;86:2958-2964.
4. Swerdlow AJ, Higgins CD, Brook CGD, Dunger DB, Hindmarsh PC, Price AJ, et al. Mortality in patients with congenital adrenal hyperplasia: a cohort study. J Pediatr 1998;133:516-520.
5. Ponsonby AL, Dwyer T, Gibbons LE, Cochrane JA, Wang YG. Factors potentiating the risk of sudden infant death syndrome associated with the prone position. N Engl J Med 1993;329:377-382.
6. Wilson RC, Mercado AB, Cheng New KC MI. Steroid 21 hydroxylase deficiency: genotype may not predict the phenotype. J Clin Endocrinol Metab 1995;80:2322-2329.
7. Joint LWPES/ESPE CAH Working Group. Consensus statement on 21-hydroxylase deficiency. J Clin Endocrinol Metab 2003;87:4048-4053.
8. Working Group on Neonatal Screening of the European Society for Paediatric Endocrinology. Procedure for neonatal screening for congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Horm Res 2001;55:201-205.
9. Pass KA, Lane PA, Fernhoff PM, Hinton CF, Panny SR, Parks JS , et al. 2nd LJ. U.S. newborn screening system guidelines II: follow-up of children, diagnosis, management, and evaluation. Statement of the Council of Regional Networks for Genetic Services (CORN). J Pediatr 2000;137:S1-S46.
10. Therrell BL. Newborn screening for congenital adrenal hyperplasia. Endocrinol Metab Clin North Am 2001;30:15-30.
11. Honour JW, Torresani T. Evaluation of neonatal screening for congenital adrenal hyperplasia. Horm Res 2001;55:206-211.
12. Medvedev NIu. Changes in the adrenals in sudden death syndrome in infants. Arkhiv Patologii 1985;47:42-47.
13. Perez-Platz U, Saeger W, Dhom G, Bajanowski T. The pathology of the adrenal glands in sudden infant death syndrome (SIDS). Int J Legal Med 1994;106:244-248.
14. Suzuki T, Kashimura S, Umetsu K. Sudden infant death syndrome: histological studies on adrenal gland and kidney. Forensic Sci Int 1980;15:41-46.